Research Centre

Go back to current news

May 19 , 2017

You are invited take part in an online survey on Canada’s needs for a pan-Canadian clinical trials organization, initiated by the Canadian Clinical Trials Coordinating Centre (CCTCC) and conducted by the Intersol Group. We thank you in advance for your participation in this survey as your input is valued.

The objectives of the survey are to:

  • Assess CCTCC’s initiatives, and their value to the Canadian clinical trials field;
  • Gather stakeholder views on any future role(s) a pan-Canadian CT organization could or should play in promoting Canada as a globally competitive destination for clinical research investment;
  • Gather stakeholder views on what pan-Canadian initiatives would support the shared goals between the current mandate of the CCTCC and other provincial and pan-Canadian organizations involved in Clinical Trials; and
  • Identify areas of need that are not currently being addressed.

All information provided and collected through this survey will be used in the creation of a ‘key findings’ report that will be developed by the Intersol Group and shared with stakeholders. We would like to reassure you that your comments will be anonymous and no responses will be attributed to individuals. We are very interested in your views and opinions and we hope you will take the time to complete the survey by May 31st, 2017.

To access the survey, please use the following link: http://bit.ly/2pVlwru

In order to gather as much feedback as possible, we also ask that you forward this invitation to relevant stakeholders who you think are able to provide valuable insight.

If you have any questions regarding the survey, please contact Sue Perron at sperron@intersol.ca or 613-850-6564.

About the CCTCC:

Established in 2014, the CCTCC was created to strengthen the Canadian clinical trials environment and promote Canada as a leading destination for clinical trials globally. The CCTCC is a unique collaboration between government – Canadian Institutes of Health Research (CIHR), industry – Innovative Medicines Canada, and healthcare institutions – HealthCareCAN.

In the past three years, the CCTCC has worked on initiatives stemming from a 2012 Action Plan aimed at strengthening and improving the clinical trials environment in Canada and some more recent needs of Canadian clinical trials field. More information on these initiatives can be found in the CCTCC 2014-2017 Report to stakeholders accessible here.

Building upon the accomplishments of the CCTCC, this is an opportune time to explore the need and role(s) that a pan-Canadian clinical trials organization could play in promoting Canada as a destination for clinical research. To this end, the CCTCC has engaged the services of the Intersol Group to conduct this strategic consultation.

 

Adapted from Intersol communication

Search Research
News Archives

Name or keyword: 7